GPR35 and Parkinson disease: The Kruskal–Wallis test and linear discriminant analysis (LDA) both indicated that the relative abundance of Lactobacillus was significantly lower in Gpr35−/− mice than in WT controls, with an additional decline under PD conditions (Fig. 2D and Fig. 2D, E, and G), highlighting its potential therapeutic implications in PD pathogenesis.